How effective is Elocon for Eczema? (a real world drug study)

Summary:

Overall ratings: 2.8/5
Long term ratings: 2.8/5

This is a phase IV clinical study of how effective Elocon (mometasone furoate) is for Eczema and for what kind of people. The study is created by eHealthMe from 6 Elocon users and is updated continuously.

What is Elocon?

Elocon has active ingredients of mometasone furoate. It is often used in eczema. eHealthMe is studying from 2,019 Elocon users. Check the latest studies of Elocon.

What is Eczema?

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters) is found to be associated with 1,491 drugs and 1,943 conditions by eHealthMe. Check the latest studies of Eczema.


On Jul, 17, 2026

6 people are studied for taking Elocon in Eczema

Overall effectiveness (number of people):

Does Elocon work for your Eczema (overall)?

Long term (1+ years) effectiveness (number of people):

Does Elocon work for your Eczema (long term)?

Elocon effectiveness for Eczema (number of people):

Overall:
  • not at all: 1
  • somewhat: 1
  • moderate: 2
  • high: 2
  • very high: 0
Long Term:
  • not at all: 1
  • somewhat: 1
  • moderate: 2
  • high: 2
  • very high: 0

Gender of people who take Elocon for Eczema *:

  • female: 50 %
  • male: 50 %

Age of people who take Elocon for Eczema *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 16.67 %
  • 20-29: 16.67 %
  • 30-39: 16.67 %
  • 40-49: 33.33 %
  • 50-59: 0.0 %
  • 60+: 16.67 %

Who find Elocon more effective for Eczema?

Gender of people who take Elocon for Eczema *:

  • female: 100 %
  • male: 0.0 %

Age of people who take Elocon for Eczema *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 50 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

* Approximation only. Some reports may have incomplete information.

Do you take Elocon?

- You can start a phase IV clinical trial to monitor Elocon safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on mometasone furoate (the active ingredients of Elocon) and Elocon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: